Published on in Vol 8, No 4 (2022): Oct-Dec
![Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study](https://asset.jmir.pub/assets/f75a0b4365a55cd4f3880e9238f0a855.png 480w,https://asset.jmir.pub/assets/f75a0b4365a55cd4f3880e9238f0a855.png 960w,https://asset.jmir.pub/assets/f75a0b4365a55cd4f3880e9238f0a855.png 1920w,https://asset.jmir.pub/assets/f75a0b4365a55cd4f3880e9238f0a855.png 2500w)
1 Biobehavioral Health Science Division, College of Nursing, University of Arizona, Tucson, AZ, United States
2 The University of Arizona Cancer Center, University of Arizona, Tucson, AZ, United States
3 Department of Neurology, School of Medicine, Oregon Health & Science University, Portland, OR, United States
4 Division of Oncological Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States
5 APDM, Inc, a division of Clario International, Portland, OR, United States
6 Division of Hematology and Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR, United States